Sequoia Capital China
VC
INVESTOR TYPE
Active
STATUS
16
PROFESSIONALS
413
INVESTMENTS
260
PORTFOLIO
82
EXITS
Description
Sequoia Capital China is a venture capital firm based in Beijing, China. The firm seeks to invest in the agriculture, distribution, B2B, education, retail, energy, financial services, healthcare and technology sectors. It primarily invests in Chinese companies. It operates as a subsidiary of Sequoia Capital.
Website
Investor Status
Actively Seeking New Investments
Year Founded
1972
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- No. 77 Jianguo Road, Chaoyang District
- Huamao Center No. 3 Office
- Beijing, 3606
- China
+86 010 0000 0000
Sequoia Capital China Investments & Acquisitions (413)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Math Planet | 30-Apr-2019 | Early Stage VC | 000 | Educational Software | Startup | |
| 0000000 | 10-Apr-2019 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 00000 | 09-Apr-2019 | 00000 00000 | 00000 | Other Restaurants, Hotels and Leisure | Generating Revenue | 0000 0000 |
| 000000000 | 29-Mar-2019 | 00000 00000 | 00000 | Automotive | Generating Revenue | |
| 00000 000000 00000 | 19-Mar-2019 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | |
| 000000 | 22-Feb-2019 | 0000 00000 | 0000 | Application Software | Startup | |
| 00000000 | 21-Feb-2019 | 00000 00000 | 00000 | Social/Platform Software | Generating Revenue | 0000 0000 |
| 0000000 0000 | 14-Feb-2019 | 00000 00000 | 00000 | Diagnostic Equipment | Generating Revenue | |
| BrightGene Bio-Medical Technology Company | 07-Jan-2019 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue | |
| Linlinyi | 02-Jan-2019 | Early Stage VC | 0000 | Application Software | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sequoia Capital China’s full profile, request a free trial.
Sequoia Capital China Exits (79)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CStone Pharmaceuticals | 26-Feb-2019 | IPO | 00000 | Completed |
|
| 0000000 0000000000 | 06-Dec-2018 | 000 | 00000 | Completed |
|
| 000 | 12-Sep-2018 | 000 | 000 | Completed |
|
| 000000 000 | 23-May-2018 | 000000000000000000 | 0000 | Completed |
|
| 00000000 | 03-Apr-2018 | 000000000000000000 | Completed |
|
|
| 000.00 | 01-Apr-2018 | 000000000000000000 | 00.00 | Completed |
|
| 000000000 | 04-Jan-2018 | 000 00 00000000 | Completed |
|
|
| 00000 | 21-Dec-2017 | 000000000000000000 | 000.00 | Completed |
|
| Fenqile | 21-Dec-2017 | IPO | 00000 | Completed |
|
| Jianpu Technology | 16-Nov-2017 | IPO | 00000 | Completed |
|
Sequoia Capital China Team (34)
13 Former Team Members
You’re viewing 5 of 34 team members. Get the full list »Sequoia Capital China Co-Investors (441)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Hillhouse Capital Group | 14 | 0 | 0 |
| Tencent Holdings | 00 | 0 | |
| IDG Capital | 00 | 0 | 0 |
| Matrix Partners China | 00 | 0 | 0 |
| GGV Capital | 00 | 0 |